MONDAY, Nov. 29, 2021 (HealthDay News) — Merck’s experimental COVID-19 antiviral pill appears effective, but may pose risks for pregnant women, including birth defects and toxicity to developing fetuses, according to the U.S. Food and Drug Administration. On Friday morning Merck announced updated results from its molnupiravir study that showedContinue Reading

WEDNESDAY, Nov. 24, 2021 (HealthDay News) — Parents and children who were separated under the Trump administration’s “zero tolerance” immigration policy have shown lasting psychological trauma — even after being reunited, a new study finds. Between 2017 and 2018, more than 5,000 children were separated from their parents at theContinue Reading